Scarabelli TM, Knight R, Stephanou A, et al. Clinical implications of apoptosis in ischemic myocardium[J]. Curr Probl Cardiol, 2006, 31(3): 181-264.
[3]
Kim JK, Pedram A, Razandi M, et al. Estrogen prevents cardiomyocyte apoptosis through inhibition of reactive oxygen species and differential regulation of p38 kinase isoforms[J]. J Biol Chem, 2006, 281(10): 6760-6767.
Giugliano RP, Newby LK, Harington RA, et al. The early glycoprotein Ⅱb/Ⅲa inhibition in non-ST-segment elevation acute coronary syndrome(EARLY ACS) trial: a randomized placebo-controlled trial evaluating the clinical benefits of early front-loaded eptifibatide in the treatment of patients with non-ST-segment elevation acute coronary syndrome--study design and rationale[J].Am Heart J, 2005; 149(6): 994-1002.
[6]
Serruys PW, Morice MC, Kappetein AP, et al. Percutaneous coronary intervention versus coronary-artery bypass grafting for severe coronary artery disease[J]. N Engl J Med, 2009, 360(10): 961-972.
[7]
Weintraub WS, Spetus JA, Kolm P, et al. Effect of PCI on quality of life in patients with stable coronary disease[J].N Engl J Med, 2008, 359(7): 677-687.
[8]
Piper HM, Garcia-Dorado D, Ovize M. A fresh look at reperfusion injury[J].Cardiovasc Res, 1998, 38(2): 291-300.
[9]
Bolli R, Becker L, Gross G, et al. Myocardialprotectionat a crossroads: the need for translationinto clinical therapy[J]. Circ Res, 2004, 95(2): 125-134.
[10]
McNeil CJ, Smith LD, Jenkins LD, et al. Hypotensive resuscitation using a polymerized bovine hemoglobin-based oxygen-carrying solution(HBOC-201) leads to reversal of anaerobic metabolism[J]. J Trauma, 2001, 50(6): 1063-1075.
[11]
Li T, Yu R, Zhang HH, et al. A method for purification and viral inactivation of human placenta hemoglobin[J]. Artif Cells Blood Substit Immobil Biotechnol, 2006, 34(2): 175-188.
[12]
Lum H, Roebuck KA. Oxidant stress and endothelial cell dysfunction[J]. Am J Physiol Cell Physiol, 2001, 280(4): 719-741.
